Clinical trialNCT00666458CompletedPhase 3Interventional

18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)

SponsorAstraZenecaEnrollment822Type 2 Diabetes

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

André Scheen, Professor
Clinical Pharmacology Unit, Liege, Belgium
Principal Investigator
clinicaltrials.gov ↗
Deborah Price, MSc
AstraZeneca, Wilmington, USA
Study Chair
clinicaltrials.gov ↗
Peter Öhman, MD, PhD
AstraZeneca, Wilmington, USA
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

87 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Buenos Aires, Buenos Aires, Argentina
Research Site
Lanus, Buenos Aires, Argentina
Research Site
Mar del Plata, Buenos Aires, Argentina
Research Site
Santa Fe, Santa Fe Province, Argentina
Research Site
Caba, Argentina
Research Site
Capital Federal, Argentina
Research Site
Ciudad de Buenos Aires, Argentina
Research Site
Córdoba, Argentina
Research Site
Rosario, Argentina

Belgium

Research Site
Aalst, Belgium, Belgium
Research Site
Bonheiden, Belgium, Belgium
Research Site
Genk, Belgium, Belgium
Research Site
Gozée, Belgium, Belgium
Research Site
Hasselt, Belgium, Belgium
Research Site
Liège, Belgium, Belgium
Research Site
Saint-Médard, Belgium, Belgium
Research Site
Sint-Gillis-Waas, Belgium, Belgium
Research Site
Tessenderlo, Belgium, Belgium
Research Site
Thuillies, Belgium, Belgium
Research Site
Bruges, Belgium

Denmark

Research Site
Aalborg, Denmark
Research Site
Aarhus, Denmark
Research Site
Christiansfeld, Denmark
Research Site
Farsø, Denmark
Research Site
Gentofte Municipality, Denmark
Research Site
Hobro, Denmark
Research Site
Kolding, Denmark
Research Site
Rødovre Municipality, Denmark
Research Site
Viborg, Denmark

France

Research Site
Angers, France
Research Site
Château-Gontier, France
Research Site
Corbeil-Essonnes, France
Research Site
La Seyne-sur-Mer, France
Research Site
Laval, France
Research Site
Le Lavandou, France
Research Site
Montrevault, France
Research Site
Saint-Cyr, France
Research Site
Tiercé, France
Research Site
Toulon, France
Research Site
Witry-lès-Reims, France

47 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2008
Primary completion: 31 Mar 2009
Completion: 31 Mar 2009
Last update posted: 15 Apr 2010
Registered enrollment: 822
Registry id: NCT00666458

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.